Resilience in Rectal Cancer Treatment: Lessons from the COVID-19 Era in Czech Republic.
Peter IhnátLubomír MartínekLubomír TulinskýZdeněk KalaTomáš GrolichRobert GurlichJan ŠturmaDušan KlosPetr ŠpičkaČestmír NeoralVladimir ČernýPublished in: Therapeutics and clinical risk management (2024)
Our study showed, that despite concerns about the COVID-19 pandemic, multimodal treatment of rectal cancer was associated with unchanged postoperative morbidity rates, increased frequency of short-course neoadjuvant RT administration and shorter "diagnosis-surgery" intervals.